DrugMonkey doesn't think much of the new NIH rules to address financial conflict of interest among researchers. In fact, he says, the tighter rules "will do absolutely nothing about real COI." For one thing, DrugMonkey says, lowering the reporting threshold from $10,000 to $5,000 won't do anything about the PIs who caused scandal and were investigated by Congress for making hundreds of thousands of dollars from big pharma without reporting it.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.